BioNTech SE: BioNTech Announces Establishment of Interdiscip

JERUSALEM, Israel, March 1, 2023 - BioNTech SE(Nasdaq: BNTX, "BioNTech", "the Company") announced that the Company and the Weizmann Institute of Science ("Weizmann Institute") signed a Memorandum

Related Keywords

Jerusalem , Israel General , Israel , Ness Ziona , Hamerkaz , State Of Israel , Dennis Riedl , Ziv Reich , Michael Horowicz , Ugur Sahin , Fosun Pharma , Genentech , Weizmann Institute Of Science , Weizmann Institute , Pfizer , Exchange Commission , Roche Group , Rna Excellence Center , Weizmann Science Park , Vice President , New Technologies , Private Securities Litigation Reform Act , Quarterly Report , Biontech , Nnounces , Establishment , Interdisciplinary , Rna , Excellence , Center , Conduct , Research , Ointly , Scientists , Rom , Weizmann , Institute , Science ,